Xcelerate Inc XCRT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if XCRT is a good fit for your portfolio.
News
-
Xcelerate, Inc. Retains Investment Bank Craft Capital Management to Provide Investment Banking and Up-Listing Advisory Services
-
Harbinger Research Issues Correction Notice for Research Report issued today pertaining to Xcelerate, Inc. (OTCQB: XCRT)
-
Xcelerate, Inc. Addresses Concerns About Recently Released Research Report
-
Harbinger Research Publishes Coverage Initiation Report on Xcelerate, Inc., a Rapidly Growing Medical AI Technology, Healthcare Services, and Skin Care Products Company
-
Xcelerate, Inc. Announces Change of Auditors
-
Xcelerate, Inc. Announces That It Has Filed Its 2023 Annual Report
Trading Information
- Previous Close Price
- $0.04
- Day Range
- $0.04–0.05
- 52-Week Range
- $0.01–0.14
- Bid/Ask
- $0.03 / $0.04
- Market Cap
- $14.65 Mil
- Volume/Avg
- 297,073 / 259,012
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Xcelerate Inc has assembled an internationally recognized team of translational clinicians, engineers and business leaders to identify, acquire, and develop engineering advancements, intellectual property and operating business in, or with applications in medical technology and clinical care. It intends to acquire innovation at the engineering/patent level, marry it with appropriate early-stage operational med-tech companies and apply it in a controlled clinical care setting which fosters engineering/clinical/business advancements under one umbrella.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Value
- Total Number of Employees
- 23
- Website
- https://www.xcelerate.global
Valuation
Metric
|
XCRT
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
XCRT
|
---|---|
Quick Ratio | 0.09 |
Current Ratio | 0.11 |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
Metric
|
XCRT
|
---|---|
Return on Assets (Normalized) | −9.40% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Medical Care Facilities Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
HCA Healthcare Inc
HCA
| Zrmqyvjx | Hdplfv | $92.9 Bil | |||
Fresenius SE & Co KGaA
FSNUF
| — | Pqkxgz | $19.5 Bil | |||
Fresenius SE & Co KGaA ADR
FSNUY
| — | Lksyww | $19.5 Bil | |||
Tenet Healthcare Corp
THC
| Ylqtjplf | Pkj | $14.8 Bil | |||
Universal Health Services Inc Class B
UHS
| — | Cmkkpq | $14.3 Bil | |||
DaVita Inc
DVA
| Tfpmbgsgw | Fkqmlk | $12.1 Bil | |||
Fresenius Medical Care AG
FMCQF
| — | Xsg | $11.8 Bil | |||
Fresenius Medical Care AG ADR
FMS
| Mzry | Gwgycd | $11.8 Bil | |||
Bangkok Dusit Medical Services PCL Shs Foreign Registered
BDULF
| — | Dpmld | $11.6 Bil | |||
AMN Healthcare Services Inc
AMN
| Hrztqxwyw | Pkrqghy | $2.4 Bil |